Skip to main content

 

Day 3 - Top 5 from EULAR 2020

These were my top abstracts from Thursday, 4th of June at EULAR 2020:

Year of the Wolf: Lupus at EULAR2020

For a disease that has been recognized since the days of Hippocrates, we are finally making some progress towards understanding systemic lupus erythematosus (SLE) and how to tame the wolf.  Listed below are the top 5 studies and their summaries presented at the recent EULAR e-Congress confer

Day 2 – Top 5 from EULAR 2020

These were my top abstracts from Thursday, 4th of June at EULAR 2020.

RheumNow Podcast – The Future of JAKs (6.5.20)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

EULAR and ACR COVID19 Guidelines: Similarities Provide Reassurance

In difficult times, it's reassuring to reflect on the similarities that bring us together. In the case of the EULAR and ACR COVID19 guidelines as discussed at #EULAR2020 by Drs.

Hydroxychloroquine Postexposure Prophylaxis for COVID-19 Fails

NEJM has reported that the use of hydroxychloroquine did not prevent symptomatic COVID-19 infection when used within 4 days after SARS-CoV-2 exposure.

Currently for persons who are COVID exposed, the standard of care is quarantine and there is no known preventative therapy.

First Look at COVID-19 Global Rheumatology Alliance Registry

Gianfresco et al have published the first peer-reviewed analysis of COVID-19 infected, rheumatic disease patients entered into the Rheumatology Global Alliance registry; showing that a) rheumatic disease patient can be infected with COVID-19, b) that DMARD and biologic use has no apparent effect

Hydroxychloroquine Improves Survival in Lupus

Hydroxychloroquine (HCQ) has dominated the news in recent weeks, because of poor outcomes reported when used in COVID patients.

Anti-TNF and CNS Events: The Link Strengthens

Patients with autoimmune diseases who were treated with tumor necrosis factor (TNF) inhibitors had an increased risk of developing inflammatory central nervous system (CNS) adverse events, a nested case-control study found.

TNR - COVID-Rheumatology Registry & COVID in OZ

This week's Tuesday Nite Rheumatology features presentations and interviews with Drs. Peter Nash and Philip Robinson. Dr. Robinson presents latest data on the Rheum-Covid.org Registry, that he helped establish under the Global Rheumatology Alliance. Dr.

The Nine Lives of Hydroxychloroquine (Updated)

Hydroxychloroquine is one of many medications frequently used in rheumatology practice.

RheumNow Podcast - COVID Kids and Men (5.15.20)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.

Social

Why Are Physicians Silent About Outrageous Drug Prices? https://t.co/hLrUFCiKwm https://t.co/ZgRoW9Duo6
Dr. John Cush @RheumNow ( View Tweet )
3 years 8 months ago
COVAX Registry: Safety of COVID-19 Vaccines in Rheum Patients  https://t.co/MrywKZKcIV https://t.co/QgajVPdesg
Dr. John Cush @RheumNow ( View Tweet )
3 years 8 months ago
Register for RheumNow Live, March 19-20, 2022. You can attend RheumNow Live in person in Irving, Texas - or, the comfort of your own home or office. You can also receive CME credit! https://t.co/fYyV75vAWm https://t.co/zOpCbBrzHJ
Dr. John Cush @RheumNow ( View Tweet )
3 years 8 months ago
Register for RheumNow Live, March 19-20, 2022. You can attend RheumNow Live in person in Irving, Texas - or, the comfort of your own home or office. You can also receive CME credit! https://t.co/cb787PiX5v https://t.co/ChAqBRCh7c
Dr. John Cush @RheumNow ( View Tweet )
3 years 8 months ago
ASK CUSH ANYTHING! Have a Rheumatology question or case for Jack Cush? Record it here and we may feature it on an upcoming podcast. Tell us your name and where you practice rheumatology. https://t.co/7q5sMQuIHj https://t.co/ksCCvzdxka
Dr. John Cush @RheumNow ( View Tweet )
3 years 8 months ago
Safety of COVID-19 Vaccines in Rheumatic Patients A multinational study shows that the use of COVID vaccination in rheumatic and musculoskeletal disease (I-RMD) is safe, well-tolerated with very rare serious adverse events (AEs). https://t.co/d30zbfa0f8 https://t.co/OM6GzAzTvQ
Dr. John Cush @RheumNow ( View Tweet )
3 years 8 months ago
Registration now open for RheumNow Live! Join us March 19-20 in Irving, TX or virtually! https://t.co/py6Gp8sPh8

Dr. John Cush @RheumNow ( View Tweet )

3 years 8 months ago
Download your RheumaKnowledgy Card https://t.co/GauMzCH5lB https://t.co/CrS7r6RAoc

Dr. John Cush @RheumNow ( View Tweet )

3 years 8 months ago
ASK CUSH ANYTHING! Have a Rheumatology question or case for Jack Cush? Record it here and we may feature it on an upcoming podcast. Tell us your name and where you practice rheumatology. https://t.co/tl3Nkxdv0B https://t.co/WwxgWGuVcC
Dr. John Cush @RheumNow ( View Tweet )
3 years 9 months ago
GRA @rheum_covid data presented by @mugartegil. African-American and Hispanic individuals with SLE have MUCH worse COVID-19 outcomes. Likely related socioeconomic and health disparities. Abstr#1933 #ACR21 @RheumNow https://t.co/YUoOeIxN7O
Richard Conway @RichardPAConway ( View Tweet )
3 years 10 months ago
×